Stroke Trial, Recruiting NCT07420374 Sponsor: University Hospital Heidelberg Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07420374
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 60 years or older
  • People who have been diagnosed with an acute ischemic stroke, a transient ischemic attack (sometimes called a "mini-stroke"), or reduced blood flow affecting vision in the eye
  • People whose symptoms began no more than 7 days before enrolling in the trial
  • People who have no new neurological symptoms, or only mild symptoms that do not significantly affect daily functioning, such that care can be safely managed without hospital admission
  • People who are able to give written consent themselves, or whose legally authorised representative can do so on their behalf if the person is not able to make that decision independently

Who may not be able to join:

  • People who urgently need surgery or a medical procedure to prevent another stroke (for example, an operation to clear a blocked artery in the neck)
  • People whose stroke symptoms have been changing or fluctuating in the 48 hours before enrolment
  • People who currently have a fever-causing infection, or an infectious disease that requires them to be kept separate from others
  • People who have significant difficulty swallowing, with a high risk of food or liquid entering the airway
  • People who have serious medical or care needs that require several days of inpatient hospital treatment
  • People who are receiving palliative (end-of-life) care that limits the use of certain diagnostic tests or treatments
  • People who have previously taken part in this ambulatory stroke unit care model
  • People who do not have statutory health insurance coverage in Germany
  • People who do not have sufficient proficiency in German to understand the study procedures and assessments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +49 6221 56 6999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Heidelberg
Registry
ClinicalTrials.gov
Start date
25 March 2026
Est. completion
1 September 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Favorable Functional Outcome at 90 Days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov